First Tokenized Medtech VC Fund

Invest in Europe's Best Ventures

Transforming the highly illiquid asset class of Swiss and European Medtech and life science venture capital investments.

Investor Registration

Our Current Portfolio:

Asset Backed

The tech industry is rapidly growing. BlueOcean Coin allows you to participate in that growth story by directly investing in an asset-backed token that includes the best medtech companies in Switzerland and Europe.

Why are asset-backed tokens better?

BlueOcean Coin is a breakthrough new asset-backed token that is directly tied to Medtech Startups. That means the intrinsic value of your BOV tokens is based on real companies with real assets and real technologies.

And when it comes to liquidity, no coin even comes close. When the underlying medtech startups are sold, the sale proceeds are used to buy back your token!

While traditional institutions fear and combat the blockchain, we have openly embraced it and see it as the logical next step in simplifying and increasing security in modern investing.

Our token is regulated, feeds the growth of the technology sector, is liquid, future-proof, and every dollar you invest goes into purchasing the startups that back each token.

We've created a new type of Digital Asset that is designed to build your wealth,not destroy it.BlueOcean Coin keeps you in control and lets you invest on your terms

How it works

Properties

Secure & Stable

You can't fool the blockchain. BlueOcean STO uses smart contracts that allow it to function like digital cash. This means less risk, less speculation, and an easy way to invest in technology.

Flexible & Liquid

When Digital Assets crash and new regulations are introduced, cashing out is nearly impossible. BlueOcean coin doesn't suffer from this problem because it is backed with existing assets:when we sell these assets,we use the proceed to buy back your tokens.

Existing & Business

BlueOcean has already invested in 5 outstanding ventures from the medical fields.One of them has been awarded in 2017&2018 as most innovative startup in Switzerland.

Regulated & Transparent

We embrace regulation and see it as a necessary stepping stone. Our vision is to make investing more accessible to every day investors like you by democratizing the entire process.

Token Economics

Advisors & Partners:5%

Referral Program: 3%

Pre Sales | 60% bonus3.2%

Pre Sales | 10% bonus40%

Main Sales41.3%

Token Option Plan7.5%

Token Economics

The BOV token will only be offered to a selected number of accredited or qualified investors. Please be informed that you need to qualify for private placement exemption (or any similar terms) in your country of residence.

Token issue: 50’000’000 issued in several batches until end of 2019.

The tokens are made according to the ERC-20 standard.

Tokens for sale: 42,254,000.

Accepted Currencies: BTC,ETH,USD,CHF

Investor Registration

ICO Rating Reviews

Roadmap

BOV

Launch of BlueOcean Ventures I

2008
BOV

Launch of BlueOcean Ventures II

2015
BOV

BlueOcean Ventures II invests in Abionic, Rheon Medical and Ava

Q3 2016
STO

STO Platform SwissVCToken is set up in Singapore

May 2018
BOV

BlueOcean Ventures II invests in Volumina Medical SA and Luciole Medicale AG

Q3 2018
STO

Start of STO Pre Sale

Q3 2018
STO

BlueOcean Ventures II has a portfolio of 6 startups

End 2018
BOV

Start of Security Token offering Main Sale

2019
STO

End of STO: 100% of STO net proceeds are invested into BlueOcean Ventures II

End 2019
STO

BOV Tokens are traded on several exchanges. First NAV of SwissVCToken is communicated

Q3 2019
BOV

Blue Ocean Ventures II has a portfolio of 8 to 12 startups

End 2019
BOV

First Portfolio Company is sold,triggering a first pay-out investors.

2020
STO

Pay-out received by SwissVCToken are 100%distributed to Token Holders

2020
BOV

Remaining Portfolio Companies are sold

2021-2025
STO

Pay-out received by SwissVCToken are 100%distributed to Token Holders

2021-2025
BOV

BlueOcean Ventures II is closed. All remaining assests are distributed to investors

End 2025
STO

Pay-out received by SwissVCToken are 100%distributed to Token Holders

End 2025

About BlueOcean

BlueOcean Ventures' team has invested in 30+ companies of which several have been successfully exited and 9 have been financed through the team’s first fund BlueOcean Ventures I, since 2008. Before launching BlueOcean Ventures I, BlueOcean team successfully held positions in strategy, finance and senior management in large corporations and start-up companies.

Characteristics of BlueOcean Ventures II

  • Launch Date: Sept 2015

  • Current Size: US$ 10M FIAT

  • Target Size: US$ 75M

  • Porfolio: Currently 5 companies; in total 8-12 companies

  • Location: Jersey, United Kingdom

  • Auditor: Mazars, a Tier 1 auditor

  • Focus: Medical technologies in Europe, most notably Switzerland

About BlueOcean

BlueOcean Ventures' team has invested in 30+ companies of which several have been successfully exited and 9 have been financed through the team’s first fund BlueOcean Ventures I, since 2008. Before launching BlueOcean Ventures I, BlueOcean team successfully held positions in strategy, finance and senior management in large corporations and start-up companies.

Characteristics of BlueOcean Ventures II

  • Launch Date: Sept 2015

  • Current Size: US$ 10M FIAT

  • Target Size: US$ 75M

  • Focus: Medical technologies in Europe, most notably Switzerland

  • Porfolio: Currently 5 companies; in total 8-12 companies

  • Location: Jersey, United Kingdom

  • Auditor: Mazars, a Tier 1 auditor

Our Startups

The clinically proven way to track your cycle

Finally understand your body. Wear the Ava bracelet at night for effortless insight about your fertility, pregnancy, and your health.

avawomen.com

The world's first adjustable glaucoma drainage system

Rheon Medical specializes in developing and distributing the world's first adjustable glaucoma drainage device

rheonmedical.com

The scaffold solving the problem of natural repair of 3D soft tissues

Volumina Medical SA develops, manufactures and commercializes highly innovative tissue reconstruction technologies for the market of reconstructive and plastic surgery.

volumina-medical.ch

Reliable ways of measuring key oxygenation and flow parameters of the brain

Luciole Medical AG develops and sells RheoPatch and RheoSens, providing reliable ways of measuring key oxygenation and flow parameters of the brain.

luciolemedical.com

The world’s fastest diagnostic platform

At the forefront of medical technology, biotechnology and nanotechnology, Abionic has developed and commercialized abioSCOPE, a unique diagnostic platform that improves medical diagnosis using a single drop of blood.

abionic.com

The clinically proven way to track your cycle

Finally understand your body. Wear the Ava bracelet at night for effortless insight about your fertility, pregnancy, and your health.

avawomen.com

The world's first adjustable glaucoma drainage system

Rheon Medical specializes in developing and distributing the world's first adjustable glaucoma drainage device

rheonmedical.com

The scaffold solving the problem of natural repair of 3D soft tissues

Volumina Medical SA develops, manufactures and commercializes highly innovative tissue reconstruction technologies for the market of reconstructive and plastic surgery.

volumina-medical.ch

Reliable ways of measuring key oxygenation and flow parameters of the brain

Luciole Medical AG develops and sells RheoPatch and RheoSens, providing reliable ways of measuring key oxygenation and flow parameters of the brain.

luciolemedical.com

The world’s fastest diagnostic platform

At the forefront of medical technology, biotechnology and nanotechnology, Abionic has developed and commercialized abioSCOPE, a unique diagnostic platform that improves medical diagnosis using a single drop of blood.

abionic.com

BlueOcean STO Team

Team

Emmanuel
de Watteville
General Partner and Co-Founder

Bio

Thomas
Zehnder
General Partner

Bio

Jean-Etienne
Durand
Head of Operations

Bio

Erik
Roussel
Fundraising

Bio

Roland
Venesz
Blockchain Architect

Bio

Christiana
Zoupa
Community Manager

Bio

Advisors

Antonio
Gambardella
Strategy Advisor

Bio

Viesturs
Tamuzs
Finance Advisor

Bio

Christophe
Saam
Patent & IP Advisor

Bio

Olivier
Crochat
Technology Advisor

Bio

Lug
Giroud
Business Development Asia

Bio